ChartMill assigns a Buy % Consensus number of 82% to BTMD. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-07 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2025-03-13 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-12-16 | Craig-Hallum | Initiate | Buy |
| 2024-03-13 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-02-20 | B. Riley Securities | Initiate | Buy |
| 2024-02-01 | Jefferies | Initiate | Buy |
| 2024-01-18 | Roth MKM | Maintains | Buy -> Buy |
| 2024-01-18 | Truist Securities | Maintains | Buy -> Buy |
| 2023-08-15 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-03-30 | Roth MKM | Maintains | Buy |
| 2022-09-27 | Truist Securities | Initiate | Buy |
| 2022-06-24 | Cowen & Co. | Initiate | Outperform |
| 2022-06-23 | Roth Capital | Initiate | Buy |
11 analysts have analysed BTMD and the average price target is 5.2 USD. This implies a price increase of 92.06% is expected in the next year compared to the current price of 2.705.
The consensus rating for BIOTE CORP -A (BTMD) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering BIOTE CORP -A (BTMD) is 11.